Genentech to bear 840 of Roche job cuts; Novartis can't pay all cash for Alcon stake;

@FiercePharma: Roche cuts 4,800 jobs, shuffles 1,500 more. Report | Follow @FiercePharma

> Genentech says it is preparing to cut 840 workers as part of Roche's overall plan to cut 4,800 jobs and shed another 1,500 via internal moves. Report 

> Novartis will not go for an all-cash deal to clinch the remaining 23 percent stake it does not already own in the eyecare group Alcon, CEO Joe Jimenez (photo) told Reuters, citing Swiss law. News

> Merck's Gardasil vaccine appears effective for preventing anal cancer, members of a U.S. advisory panel said. Article

> Ista Pharmaceuticals said U.S. health regulators granted three years of market exclusivity for its recently approved eye drops. Report

> European pharma companies will face major challenges over the next three years implementing new regulatory legislation and compliance requirements, according to a new report. Story

> There are "many limitations" to how drug safety and effectiveness is monitored and reported in Canada and "vast improvements" are needed, says a new report. News

> Swiss drugmaker Roche wants to sell its Boulder production plant to another company that will use it to supply Roche with the drug compounds produced there. Report

> Pfizer's Wyeth unit downplayed the risks that its Prempro menopause drug could cause breast cancer, a lawyer for a Virginia woman who developed the disease told jurors. Item

Biotech News

 @FierceBiotech: Merck cites "jaw dropping" data on cholesterol blockbuster contender. Story | Follow @FierceBiotech

 @JohnCFierce: Actelion shares red hot after co. merely noted that it is always engaged in routine talks with other companies. Report | Follow @JohnCFierce

> Resverlogix shares crater after cholesterol drug disappoints in PhII. Article 

> Roche drops a bomb on the RNAi field. Item 

> Vernalis spikes troubled V3381 program. Story 

Vaccines News

> New vaccine offers hope in fight against pneumonia, meningtis. News

> Health officials call for universal whooping cough, flu vax adult administration. Article 

> UC Irvine team: Alzheimer's vax shows promise. Report 

> Sanofi's Shantha buyout fails to live up to expectations. Item

Manufacturing News

> Mold, ceiling holes cited in CP Pharma warning. Report

> Sanofi/Shantha vax fix will require WHO requalification. Article

> Vial cracking causes halt in lupus drug trial. Item

> RFID system balances readability, price and data. News 

> Metrics unveils PharmaVision channel for outsourced work. Report 

> USP database to track fakes. Story 

And Finally... Scientists have developed a way of smuggling an anti-cancer drug past the protective blood-brain barrier using a nanocarrier--a tiny capsule specially designed to deliver its anti-cancer drug to the cancer cell. Report

Suggested Articles

Talk about making pharma history. Merck's Keytruda has racked up yet another first-of-its-kind approval, this time in a combo with Eisai’s Lenvima.

In an era of limited access to key decision makers, how are you mobilizing your field force to communicate the value of your brands and real-world evidence?

Novo Nordisk’s Ozempic is off to a blazing start, and the company just threw more fuel on the fire with a pair of trial wins.